FDA makes example out of Chinese OTC manufacturer
The FDA posted a public missive alongside a warning letter to a Chinese OTC drug manufacturer, highlighting the efforts it had been making to address data integrity issues.
Archives for August 23, 2019
A model summer: Preclinical research developments rise with the temperature
As summer heated up, the pharmaceutical industry saw major developments in preclinical models from new software to 3D-printed tissue, all in the name of drug development.